2022 FIC Exhibition | Bloomage Biotech launches AbateHP™- the new anti-Helicobacter pylori solution

2022.08.19

From August 16th to 18th, the 25th China International Food Additives and Ingredients Exhibition (FIC2022) was successfully held in Guangzhou. Bloomage Biotech brought scenario-based solutions to this exhibition, such as oral beauty, bone and joint health, gastrointestinal health, and sleep health. Also, held the"Bloomage Biotech 2022 AbateHP™ New Product Launch Conference" to launch the anti-Helicobacter pylori solution.

一群人站在台上

中度可信度描述已自动生成

Worldwide >85% of gastric cancers are attributed to Helicobacter pylori infection, and China is a high incidence area of Helicobacter pylori infection. As people pay more attention to health, more and more people will actively participate in treatment after being diagnosed with Helicobacter pylori.

一群人站在室内

中度可信度描述已自动生成一群人正在聊天

描述已自动生成

At the Bloomage Biotech 2022 AbateHP™ New Product Launch Conference, Bloomage Biotech and many experts from the industry discussed the gastrointestinal market trend, clinical research on Helicobacter pylori infection and the application plan of anti-pylori bioactive substances. With the help of this product technology seminar, Bloomage Biotech hopes to work with industry experts to improve the industry's understanding of Helicobacter pylori and provide more scientific and practical anti-pylori solutions.

一群人在开会

描述已自动生成男人和女人在电视前

中度可信度描述已自动生成

In addition to AbateHP™, Bloomage Biotech also fully demonstrated the application of sodium hyaluronate in oral beauty, bone and joint maintenance, intestinal health and other fields.